AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
If your food was affected, do not eat it - instead, Birds Eye has asked customers to return the packaging to the shop where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback